New anesthesia cocktail may cut confusion and pain after heart surgery
NCT ID NCT05279898
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a combination of brain monitoring and specific drugs during heart surgery to see if it could reduce confusion, pain, and blood pressure problems afterward. 70 older adults (60+) having heart bypass or valve surgery took part. The approach used EEG monitoring and a mix of painkillers and sedatives to tailor anesthesia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ropivacaine, Ketamine, Remifentanil, Dexmedetomidine
- What this could lead to
- If successful, this approach could help older adults recover from heart surgery with less confusion, pain, and need for strong painkillers.
- What could go wrong
- This is a small, completed study (70 people) without a phase, so results may not apply to everyone. The benefits seen might not hold up in larger, more diverse groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Software-Guided heart procedures: a new standard for coronary care?
- Virtual reality may distract patients from pain and fear during anesthesia
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program